Revisiting the BIOSCIENCE of drug-eluting stent technology

Affiliations

¹ Munich University Clinic, Ludwig-Maximilians University, Munich 81377, Germany; DZHK (German Center for Cardiovascular Research), Munich Heart Alliance, Munich, Germany. Electronic address: julinda.mehilli@med.uni-muenchen.de.
² Munich University Clinic, Ludwig-Maximilians University, Munich 81377, Germany; DZHK (German Center for Cardiovascular Research), Munich Heart Alliance, Munich, Germany.

Comment

Julinda Mehilli et al. Lancet. 2014.

. 2014 Dec 13;384(9960):2086-8.

doi: 10.1016/S0140-6736(14)61415-X. Epub 2014 Sep 1.

¹ Munich University Clinic, Ludwig-Maximilians University, Munich 81377, Germany; DZHK (German Center for Cardiovascular Research), Munich Heart Alliance, Munich, Germany. Electronic address: julinda.mehilli@med.uni-muenchen.de.
² Munich University Clinic, Ludwig-Maximilians University, Munich 81377, Germany; DZHK (German Center for Cardiovascular Research), Munich Heart Alliance, Munich, Germany.

No abstract available

Comment on

Ultrathin strut biodegradable polymer sirolimus-eluting stent versus durable polymer everolimus-eluting stent for percutaneous coronary revascularisation (BIOSCIENCE): a randomised, single-blind, non-inferiority trial.
Pilgrim T, Heg D, Roffi M, Tüller D, Muller O, Vuilliomenet A, Cook S, Weilenmann D, Kaiser C, Jamshidi P, Fahrni T, Moschovitis A, Noble S, Eberli FR, Wenaweser P, Jüni P, Windecker S. Pilgrim T, et al. Lancet. 2014 Dec 13;384(9960):2111-22. doi: 10.1016/S0140-6736(14)61038-2. Epub 2014 Sep 1. Lancet. 2014. PMID: 25189359 Clinical Trial.